Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (121-130 of 541) with videos related to

Pageof 55
Sort By:
European Journal of Heart Failure|October 26, 2023
Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure RegistryNicolas Girerd, Stefano Coiro, Lina Benson, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomasLaurence Amar, Séverine Peyrard, Patrick Rossignol, et al.
Kidney360|April 4, 2022
Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER TrialRajiv Agarwal, Patrick Rossignol, Jeffrey Budden, et al.
The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.
Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.
Heart Failure Reviews|August 29, 2022
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fractionStefano Coiro, Olivier Huttin, Masatake Kobayashi, et al.
Fundamental & Clinical Pharmacology|October 24, 2020
Dyskalemia: a management problem for studentsLisa Senninger, Laure Abensur Vuillaume, Luc Frimat, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 19, 2006
Inflammatory F-18 fluorodeoxyglucose uptake over arterial bypass prosthesis seen on positron emission tomography can predict acute vascular eventsMichèle Duet, Jean Pierre Laissy, Benoit Paulmier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 24, 2021
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with DiabetesRajiv Agarwal, Patrick Rossignol, Martha R Mayo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 2, 2017
Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year surveyPatrick Rossignol, Zohra Lamiral, Luc Frimat, et al.
Pageof 55

Showing results (121-130 of 541) with videos related to

Sort By:
Pageof 55
European Journal of Heart Failure|October 26, 2023
Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure RegistryNicolas Girerd, Stefano Coiro, Lina Benson, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomasLaurence Amar, Séverine Peyrard, Patrick Rossignol, et al.
Kidney360|April 4, 2022
Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER TrialRajiv Agarwal, Patrick Rossignol, Jeffrey Budden, et al.
The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.
Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.
Heart Failure Reviews|August 29, 2022
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fractionStefano Coiro, Olivier Huttin, Masatake Kobayashi, et al.
Fundamental & Clinical Pharmacology|October 24, 2020
Dyskalemia: a management problem for studentsLisa Senninger, Laure Abensur Vuillaume, Luc Frimat, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 19, 2006
Inflammatory F-18 fluorodeoxyglucose uptake over arterial bypass prosthesis seen on positron emission tomography can predict acute vascular eventsMichèle Duet, Jean Pierre Laissy, Benoit Paulmier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 24, 2021
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with DiabetesRajiv Agarwal, Patrick Rossignol, Martha R Mayo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 2, 2017
Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year surveyPatrick Rossignol, Zohra Lamiral, Luc Frimat, et al.
Pageof 55